Targeting tumor antigens to dendritic cells using particulate carriers

Journal of Controlled Release

Volumn 161, Issue 1, 2012, Pages 25-37

  Joshi, Medha D ^a   Unger, Wendy J ^b   Storm, Gert ^c   Van Kooyk, Yvette ^b   Mastrobattista, Enrico ^c  

^a MIDWESTERN UNIVERSITY   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

CTL response; Dendritic cells; Liposomes; Nanoparticles; Targeting; Vaccine

Indexed keywords

ACTIVE TARGETING; ANTIGEN PRESENTATION; ANTITUMOR IMMUNITY; CELL-PENETRATING PEPTIDE; CTL RESPONSE; CYTOTOXIC T LYMPHOCYTES; DENDRITIC CELLS; FC-RECEPTORS; NANOCARRIERS; PASSIVE TARGETING; PH SENSITIVE; PHYSICOCHEMICAL PARAMETERS; POLYMERIC NANOPARTICLES; TARGETING; TUMOR ANTIGEN;

ANTIGENS; LIPOSOMES; NANOPARTICLES; TUMORS; VACCINES;

CELLS;

CATION; CD11 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; FC RECEPTOR; FLT3 LIGAND; LIPID; LIPOSOME; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNOSE; MANNOSE RECEPTOR; MELAN A; NANOPARTICLE; NANOSPHERE; NIOSOME; OLIGONUCLEOTIDE; OVALBUMIN; POLYMER; TETANUS TOXOID; TUMOR ANTIGEN; TUMOR VACCINE; TYROSINASE RELATED PROTEIN 2; VIROSOME;

ANTIGEN PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOSTIMULATION; IMMUNOTHERAPY; MEMBRANE MICROPARTICLE; MICROPARTICLE ENZYME IMMUNOASSAY; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SKIN; TUMOR IMMUNITY; UTERINE CERVIX CANCER; VIRUS LIKE AGENT;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; NANOPARTICLES; NEOPLASMS;

EID: 84862600932     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.05.010     Document Type: Review

References (124)

1. J. Banchereau, R.M. Steinman, Dendritic cells and the control of immunity, Nature 392 (1998) 245.
2. J. Banchereau, A.K. Palucka, Dendritic cells as therapeutic vaccines against cancer, Nat. Rev. Immunol. 5 (2005) 296-306. (Pubitemid 40516155)
3. F. Nestle, J. Banchereau, D. Hart, Dendritic cells: on the move from bench to bedside, Nat. Med. 7 (2001) 761-765. (Pubitemid 32691622)
4. D.M. Andrews, E. Maraskovsky, M.J. Smyth, Cancer vaccines for established cancer: how to make them better? Immunol. Rev. 222 (2008) 242-255. (Pubitemid 351430374)
5. F.O. Nestle, A. Farkas, C. Conrad, Dendritic-cell-based therapeutic vaccination against cancer, Curr. Opin. Immunol. 17 (2005) 163-169. (Pubitemid 40343103)
6. A.O. Hovden, S. Appel, The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA, Scand. J. Immunol. 72 (2010) 554-554.
7. P.J. Tacken, I.J.M. De Vries, R. Torensma, C.G. Figdor, Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting, Nat. Rev. Immunol. 7 (2007) 790-802. (Pubitemid 47480309)
8. W.M. Li, W.H. Dragowska, M.B. Bally, M.P. Schutze-Redelmeier, Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes, Vaccine 21 (2003) 3319-3329. (Pubitemid 36694572)
9. P. Laing, A. Bacon, B. McCormack, G. Gregoriadis, B.t. Frisch, F. Schuber, The "Codelivery"™ approach to liposomal vaccines: application to the development of influenza-A and hepatitis-B vaccine candidates, J. Liposome Res. 16 (2006) 229-235. (Pubitemid 44358996)
10. S. Shrivastava, K.S. Lole, A.S. Tripathy, U.S. Shaligram, V.A. Arankalle, Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach, Vaccine 27 (2009) 6582-6588.
11. A. Lahiri, P. Das, D. Chakravortty, Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond, Vaccine 26 (2008) 6777-6783.
12. M.J. Bevan, Cross-priming, Nat. Immunol. 7 (2006) 363-365.
13. L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M.C. Nussenzweig, R.M. Steinman, Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance, J. Exp. Med. 196 (2002) 1627-1638. (Pubitemid 36026474)
14. D. Hawiger, K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, M.C. Nussenzweig, Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo, J. Exp. Med. 194 (2001) 769-779. (Pubitemid 32983013)
15. S.D. Xiang, A. Scholzen, G. Minigo, C. David, V. Apostolopoulos, P.L. Mottram, M. Plebanski, Pathogen recognition and development of particulate vaccines: does size matter? Methods 40 (2006) 1-9. (Pubitemid 44415493)
16. M.C. Garnett, P. Kallinteri, Nanomedicines and nanotoxicology: some physiological principles, Occup. Med. (Lond) 56 (2006) 307-311. (Pubitemid 44304821)
17. J.C. Reece, N.J. Vardaxis, J.A. Marshall, S.M. Crowe, P.U. Cameron, Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes, Immunol. Cell Biol. 79 (2001) 255-263. (Pubitemid 32522174)
18. C. Foged, B. Brodin, S. Frokjaer, A. Sundblad, Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model, Int. J. Pharm. 298 (2005) 315-322. (Pubitemid 40910735)
19. P.A. Karalkin, A.Y. Lupatov, K.N. Yarygin, Endocytosis of micro- and nanosized particles in vitro by human dendritic cells, Biochemistry (Moscow) Suppl. Ser. A: Membr. Cell Biol. 3 (2009) 410-416.
20. L. Rettig, S.P. Haen, A.G. Bittermann, L. von Boehmer, A. Curioni, S.D. Kramer, A. Knuth, S. Pascolo, Particle size and activation threshold: a new dimension of danger signaling, Blood 115 (2010) 4533-4541.
21. K.K. Tran, H. Shen, The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells, Biomaterials 30 (2009) 1356-1362.
22. C. Foged, C. Arigita, A. Sundblad, W. Jiskoot, G. Storm, S. Frokjaer, Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition, Vaccine 22 (2004) 1903-1913. (Pubitemid 38581059)
23. C. Foged, A. Sundblad, L. Hovgaard, Targeting vaccines to dendritic cells, Pharm. Res. 19 (2002) 229-238. (Pubitemid 34211837)
24. E. Shahum, H.M. Therien, Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells, Int. Immunopharmacol. 2 (2002) 591-601. (Pubitemid 34169753)
25. M. Adamina, M. Bolli, F. Albo, A. Cavazza, P. Zajac, E. Padovan, R. Schumacher, A. Reschner, C. Feder, W.R. Marti, D. Oertli, M. Heberer, G.C. Spagnoli, Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanomaassociated Melan-A/MART-I epitopes, Br. J. Cancer 90 (2004) 263-269. (Pubitemid 38174970)
26. V. Jerome, A. Graser, R. Muller, R.E. Kontermann, A. Konur, Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant, J. Immunother. 29 (2006) 294-305. (Pubitemid 44297297)
27. N.J. Steers, C.R. Alving, M. Rao, Modulation of immunoproteasome subunits by liposomal lipid A, Vaccine 26 (2008) 2849-2859.
28. G.D. Sprott, D.L. Tolson, G.B. Patel, Archaeosomes as novel antigen delivery systems, FEMS Microbiol. Lett. 154 (1997) 17-22. (Pubitemid 27376731)
29. L. Krishnan, S. Sad, G.B. Patel, G.D. Sprott, The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo, J. Immunol. 166 (2001) 1885-1893. (Pubitemid 32114675)
30. L. Krishnan, S. Sad, G.B. Patel, G.D. Sprott, Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge, Cancer Res. 63 (2003) 2526-2534. (Pubitemid 36605193)
31. G.D. Sprott, S. Sad, L.P. Fleming, C.J. Dicaire, G.B. Patel, L. Krishnan, Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen, Archaea 1 (2003) 151-164. (Pubitemid 38871643)
32. G.D. Sprott, C.J. Dicaire, K. Gurnani, L.A. Deschatelets, L. Krishnan, Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses, Vaccine 22 (2004) 2154-2162. (Pubitemid 38626053)
33. G.D. Sprott, C.J. Dicaire, K. Gurnani, S. Sad, L. Krishnan, Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-GueÌrin and adjuvant activity in vivo, Infect. Immun. 72 (2004) 5235-5246. (Pubitemid 39223409)
34. E. Touitou, N. Dayan, L. Bergelson, B. Godin, M. Eliaz, Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties, J. Control. Release 65 (2000) 403-418. (Pubitemid 30122942)
35. D. Mishra, P.K. Mishra, V. Dubey, S. Dabadghao, N.K. Jain, Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes, Vaccine 25 (2007) 6939-6944. (Pubitemid 47391101)
36. D.Mishra, P.K.Mishra, S. Dabadghao, V. Dubey,M. Nahar, N.K. Jain, Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response, Nanomedicine 6 (2010) 110-118.
37. N.C. Robson, A.M. Donachie, A.M. Mowat, Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells, Eur. J. Immunol. 38 (2008) 1238-1246.
38. A.M. Mowat, Dendritic cells and immune responses to orally administered antigens, Vaccine 23 (2005) 1797-1799. (Pubitemid 40331847)
39. S.P. Vyas, R.P. Singh, S. Jain, V. Mishra, S. Mahor, P. Singh, P.N. Gupta, A. Rawat, P. Dubey, Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B, Int. J. Pharm. 296 (2005) 80-86. (Pubitemid 40693375)
40. I. Toth, P. Simerska, Y. Fujita, Recent advances in design and synthesis of self-adjuvanting lipopeptide vaccines, Int. J. Pept. Res. Ther. 14 (2008) 333-340.
41. P.M. Moyle, Y. Hari, N. Huang, C. Olive, M.F. Good, I. Toth, A technique for the synthesis of highly-pure, mono-epitopic, multi-valent lipid core peptide vaccines, Tetrahedron Lett. 48 (2007) 4965-4967. (Pubitemid 46921247)
42. L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H.P. Merkle, E. Walter, Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J. Control. Release 76 (2001) 59-71. (Pubitemid 32786885)
43. R. Ignatius, K. Mahnke, M. Rivera, K. Hong, F. Isdell, R.M. Steinman, M. Pope, L. Stamatatos, Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo, Blood 96 (2000) 3505-3513.
44. H. Aoki, M. Mizuno, A. Natsume, T. Tsugawa, K. Tsujimura, T. Takahashi, J. Yoshida, Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of clytotoxic T lymphocytes in mouse brain tumor, Cancer Immunol. Immunother. 50 (2001) 463-468. (Pubitemid 33079342)
45. Y. Suzuki, D. Wakita, K. Chamoto, Y. Narita, T. Tsuji, T. Takeshima, H. Gyobu, Y. Kawarada, S. Kondo, S. Akira, H. Katoh, H. Ikeda, T. Nishimura, Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity, Cancer Res. 64 (2004) 8754-8760. (Pubitemid 39552093)
46. G. Chikh, M. Bally, M.P. Schutze-Redelmeier, Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes, J. Immunol. Methods 254 (2001) 119-135. (Pubitemid 32530753)
47. G.G. Chikh, S. Kong, M.B. Bally, J.C. Meunier, M.P.M. Schutze-Redelmeier, Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells, J. Immunol. 167 (2001) 6462-6470. (Pubitemid 33081580)
48. K. Smith Korsholm, E.M. Agger, C. Foged, D. Christensen, J. Dietrich, C.S. Andersen, C. Geisler, P. Andersen, The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes, Immunology 121 (2007) 216-226. (Pubitemid 46663090)
49. V.W. Bramwell, Y. Perrie, Particulate delivery systems for vaccines: what can we expect? J. Pharm. Pharmacol. 58 (2006) 717-728. (Pubitemid 43836159)
50. R. Audran, K. Peter, J. Dannull, Y. Men, E. Scandella, M. Groettrup, B. Gander, G. Corradin, Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro, Vaccine 21 (2003) 1250-1255. (Pubitemid 36139957)
51. K.D. Newman, P. Elamanchili, G.S. Kwon, J. Samuel, Uptake of poly(D,L-lactic-coglycolic acid) microspheres by antigen-presenting cells in vivo, J. Biomed. Mater. Res. 60 (2002) 480-486.
52. H. Sun, K.G.J. Pollock, J.M. Brewer, Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro, Vaccine 21 (2003) 849-855. (Pubitemid 36131100)
53. C. Wischke, J. Zimmermann, B. Wessinger, A. Schendler, H.-H. Borchert, J.H. Peters, T. Nesselhut, D.R. Lorenzen, Poly(I:C) coated PLGA microparticles induce dendritic cell maturation, Int. J. Pharm. 365 (2009) 61-68.
54. X. Zhang, C.E. Dahle, G.J. Weiner, A.K. Salem, A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles, J. Pharm. Sci. 96 (2007) 3283-3292.
55. M.E.C. Lutsiak, D.R. Robinson, C. Coester, G.S. Kwon, J. Samuel, Analysis of poly(D, L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro, Pharm. Res. 19 (2002) 1480-1487. (Pubitemid 35266552)
56. M. Diwan, P. Elamanchili, H. Lane, A. Gainer, J. Samuel, Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses, J. Drug Target. 11 (2003) 495-507. (Pubitemid 38519159)
57. P. Elamanchili, M. Diwan, M. Cao, J. Samuel, Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells, Vaccine 22 (2004) 2406-2412. (Pubitemid 38757337)
58. S. Hamdy, P. Elamanchili, A. Alshamsan, O. Molavi, T. Satou, J. Samuel, Enhanced antigen-specific primary CD4 and CD8 responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D, L-lactic-co-glycolic acid) nanoparticles, J. Biomed. Mater. Res. A 81A (2007) 652-662. (Pubitemid 46786896)
59. P. Elamanchili, C.M.E. Lutsiak, S. Hamdy, M. Diwan, J. Samuel, "Pathogen-mimicking"nanoparticles for vaccine delivery to dendritic cells, J. Immunother. 30 (2007) 378-395. (Pubitemid 46684428)
60. C.M. Solbrig, J.K. Saucier-Sawyer, V. Cody, W.M. Saltzman, D.J. Hanlon, Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells, Mol. Pharm. 4 (2007) 47-57.
61. T. Gerelchuluun, Y. Lee, Y. Lee, S.-A. Im, S. Song, J. Park, K. Han, K. Kim, C. Lee, Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D, L-lactide-co-glycolide), via an alternate class I MHC processing pathway, Arch. Pharm. Res. 30 (2007) 1440-1446.
62. R. Han, J. Zhu, X. Yang, H. Xu, Surface modification of poly(D, L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells, J. Biomed. Mater. Res. A 96 A (2011) 142-149.
63. Z. Zhang, S. Tongchusak, Y. Mizukami, Y.J. Kang, T. Ioji, M. Touma, B. Reinhold, D.B. Keskin, E.L. Reinherz, T. Sasada, Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery, Biomaterials 32 (2011) 3666-3678.
64. D.J. Hanlon, P.B. Aldo, L. Devine, A.B. Alvero, A.K. Engberg, R. Edelson, G. Mor, Enhanced stimulation of anti-ovarian cancer CD8+ T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen, Am. J. Reprod. Immunol. 65 (2011) 597-609.
65. C. Clawson, C.T. Huang, D. Futalan, D. Martin Seible, R. Saenz, M. Larsson, W. Ma, B. Minev, F. Zhang, M. Ozkan, C. Ozkan, S. Esener, D. Messmer, Delivery of a peptide via poly(D, L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity, Nanomedicine 6 (2010) 651-661.
66. S.T. Reddy, A. Rehor, H.G. Schmoekel, J.A. Hubbell, M.A. Swartz, In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles, J. Control. Release 112 (2006) 26-34.
67. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, J.A. Hubbell, Exploiting lymphatic transport and complement activation in nanoparticle vaccines, Nat. Biotechnol. 25 (2007) 1159-1164. (Pubitemid 47538111)
68. X. Wang, T. Uto, K. Sato, K. Ide, T. Akagi, M. Okamoto, T. Kaneko, M. Akashi, M. Baba, Potent activation of antigen-specific T cells by antigen-loaded nanospheres, Immunol. Lett. 98 (2005) 123-130. (Pubitemid 40409827)
69. P.J. Tacken, R. Torensma, C.G. Figdor, Targeting antigens to dendritic cells in vivo, Immunobiology 211 (2006) 599-608.
70. V. Karanikas, L.A. Hwang, J. Pearson, C.S. Ong, V. Apostolopoulos, H. Vaughan, P.X. Xing, G. Jamieson, G. Pietersz, B. Tait, R. Broadbent, G. Thynne, I.F.C. McKenzie, Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein, J. Clin. Invest. 100 (1997) 2783-2792. (Pubitemid 28007547)
71. V. Apostolopoulos, V. Karanikas, J.S. Haurum, I.F. McKenzie, Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen, J. Immunol. 159 (1997) 5211-5218. (Pubitemid 127470046)
72. M.J. Copland, M.A. Baird, T. Rades, J.L. McKenzie, B. Becker, F. Reck, P.C. Tyler, N.M. Davies, Liposomal delivery of antigen to human dendritic cells, Vaccine 21 (2003) 883-890. (Pubitemid 36126422)
73. K. Serre, P. Machy, J.C. Grivel, G. Jolly, N. Brun, J. Barbet, L. Leserman, Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells, J. Immunol. 161 (1998) 6059-6067. (Pubitemid 28535976)
74. K. Kawamura, N. Kadowaki, R. Suzuki, S. Udagawa, S. Kasaoka, N. Utoguchi, T. Kitawaki, N. Sugimoto, N. Okada, K. Maruyama, T. Uchiyama, Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity, J. Immunother. 29 (2006) 165-174.
75. D.L. Mallery, W.A. McEwan, S.R. Bidgood, G.J. Towers, C.M. Johnson, L.C. James, Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21), Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 19985-19990.
76. R. Suzuki, N. Utoguchi, K. Kawamura, N. Kadowaki, N. Okada, T. Takizawa, T. Uchiyama, K. Maruyama, Development of effective antigen delivery carrier to dendritic cells via Fc receptor in cancer immunotherapy, Yakugaku Zasshi 127 (2007) 301-306. (Pubitemid 46203273)
77. C.L. Van Broekhoven, C.R. Parish, C. Demangel, W.J. Britton, J.G. Altin, Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy, Cancer Res. 64 (2004) 4357-4365. (Pubitemid 38802444)
78. A. Cambi, D.S. Lidke, D.J. Arndt-Jovin, C.G. Figdor, T.M. Jovin, Ligand-conjugated quantum dots monitor antigen uptake and processing by dendritic cells, Nano Lett. 7 (2007) 970-977. (Pubitemid 46717743)
79. L.J. Cruz, F. Rueda, B.a. Cordobilla, L. Simón, L. Hosta, F. Albericio, J.C. Domingo, Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy, Mol. Pharm. 8 (2010) 104-116.
80. C. Arigita, L. Bevaart, L.A. Everse, G.A. Koning, W.E. Hennink, D.J.A. Crommelin, J.G.J. Van de Winkel, M.J. Van Vugt, G.F.A. Kersten, W. Jiskoot, Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response, Infect. Immun. 71 (2003) 5210-5218. (Pubitemid 37070766)
81. S. Espuelas, P. Haller, F. Schuber, B. Frisch, Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers, Bioorg. Med. Chem. Lett. 13 (2003) 2557-2560. (Pubitemid 36830772)
82. S. Espuelas, C. Thumann, B.a. Heurtault, F. Schuber, B.t. Frisch, Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes, Bioconjug. Chem. 19 (2008) 2385-2393.
83. K.L. White, T. Rades, S. Hook, R.H. Furneaux, P.C. Tyler, Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells, J. Pharm. Pharmacol. 58 (2006) 729-737. (Pubitemid 43836160)
84. K. Sheng, M. Kalkanidis, D.S. Pouniotis, S. Esparon, C.K. Tang, V. Apostolopoulos, G.A. Pietersz, Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo, Eur. J. Immunol. 38 (2008) 424-436.
85. P. Chenevier, C. Grandjean, E. Loing, F. Malingue, G. Angyalosi, H. Gras-Masse, D. Roux, O. Melnyk, L. Bourel-Bonnet, Grafting of synthetic mannose receptor-ligands onto onion vectors for human dendritic cells targeting, Chem. Commun. (2002) 2446-2447. (Pubitemid 35283663)
86. S. Hamdy, A. Haddadi, A. Shayeganpour, J. Samuel, A. Lavasanifar, Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles, Pharm. Res. (2011) 1-14.
87. M. Ishii, C. Kato, A. Hakamata, N. Kojima, Targeting with oligomannose-coated liposomes promotes maturation and splenic trafficking of dendritic cells in the peritoneal cavity, Int. Immunopharmacol. 11 (2011) 164-171.
88. K. Serre, L. Giraudo, L. Leserman, P. Machy, Liposomes targeted to Fc receptors for antigen presentation by dendritic cells in vitro and in vivo, Methods Enzymol. 373 (2003) 100-118. (Pubitemid 41103278)
89. V. Buatois, M. Baillet, S. Becart, N. Mooney, L. Leserman, P. Machy, MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype, J. Immunol. 171 (2003) 5812-5819. (Pubitemid 37467197)
90. P. Machy, K. Serre, K.S.L. Leserman, Class I-restricted presentation of exogenous antigen acquired by Fc gamma receptor-mediated endocytosis is regulated in dendritic cells, Eur. J. Immunol. 30 (2000) 848-857. (Pubitemid 30216258)
91. A. Badiee, N. Davies, K. McDonald, K. Radford, H. Michiue, D. Hart, M. Kato, Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205, Vaccine 25 (2007) 4757-4766. (Pubitemid 46818617)
92. W.W. Wang, D. Das, M.R. Suresh, A versatile bifunctional dendritic cell targeting vaccine vector, Mol. Pharm. 6 (2009) 158-172.
93. Y.J. Kwon, E. James, N. Shastri, J.M.J. Frechet, In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18264-18268. (Pubitemid 43011215)
94. R.K. Gieseler, G. Marquitan, M.J. Hahn, L.A. Perdon, W.H.P. Driessen, S.M. Sullivan, M.J. Scolaro, DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease, Scand. J. Immunol. 59 (2004) 415-424. (Pubitemid 38725550)
95. L.J. Cruz, P.J. Tacken, R. Fokkink, B. Joosten, M. Cohen Stuart, F. Albericio, R. Torensma, C.G. Figdor, Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro, J. Control. Release 133 (2009) 191-197.
96. L.J. Cruz, P.J. Tacken, R. Fokkink, C.G. Figdor, The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells, Biomaterials 32 (2011) 6791-6803.
97. M.D. Joshi, W.W.J. Unger, A.J. van Beelen, S.C. Bruijns, M. Litjens, L. van Bloois, H. Kalay, Y. van Kooyk, G. Storm, DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations, Int. J. Pharm. 416 (2011) 426-432.
98. W.W.J. Unger, A.J. van Beelen, S.C. Bruijns, M. Joshi, C.M. Fehres, L. van Bloois, M.I. Verstege, M. Ambrosini, H. Kalay, K. Nazmi, J.G. Bolscher, E. Hooijberg, T.D. de Gruijl, G. Storm, Y. van Kooyk, Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells, J. Control. Release (2012), http://dx.doi.org/10.1016/j.jconrel.2012.02.007.
99. S. Nair, F. Zhou, R. Reddy, L. Huang, B.T. Rouse, Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro, J. Exp. Med. 175 (1992) 609-612.
100. S. Nair, J.S. Babu, R.G. Dunham, P. Kanda, R.L. Burke, B.T. Rouse, Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells, J. Virol. 67 (1993) 4062-4069. (Pubitemid 23180731)
101. S. Nair, A.M.J. Buiting, R.J.D. Rouse, N. Van Rooijen, L. Huang, B.T. Rouse, Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses, Int. Immunol. 7 (1995) 679-688.
102. E.M. Stier, M. Mandal, K.D. Lee, Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells, Mol. Pharm. 2 (2005) 74-82. (Pubitemid 40314732)
103. M.J. Heffernan, S.P. Kasturi, S.C. Yang, B. Pulendran, N. Murthy, The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid), Biomaterials 30 (2009) 910-918.
104. Y. Hu, T. Litwin, A.R. Nagaraja, B. Kwong, J. Katz, N. Watson, D.J. Irvine, Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive Coreâ∧'shell nanoparticles, Nano Lett. 7 (2007) 3056-3064. (Pubitemid 350132930)
105. T. Yoshikawa, N. Okada, M. Tsujino, J.Q. Gao, A. Hayashi, Y. Tsutsumi, T. Mayumi, A. Yamamoto, S. Nakagawa, Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma, Biol. Pharm. Bull. 29 (2006) 100-104. (Pubitemid 43036703)
106. E. Yuba, C. Kojima, A. Harada, Tana, S. Watarai, K. Kono, pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity, Biomaterials 31 (2010) 943-951.
107. T. Nakamura, R. Moriguchi, K. Kogure, N. Shastri, H. Harashima, Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes, Mol. Ther. 16 (2008) 1507-1514.
108. R. Suzuki, Y. Oda, N. Utoguchi, E. Namai, Y. Taira, N. Okada, N. Kadowaki, T. Kodama, K. Tachibana, K. Maruyama, A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy, J. Control. Release 133 (2009) 198-205.
109. P. Banerjee, A. Biswas, T. Biswas, Porin-incorporated liposome induces Toll-like receptors 2- and 6-dependent maturation and type 1 response of dendritic cell, Int. Immunol. 20 (2008) 1551-1563.
110. L. Bungener, A. Huckriede, J. Wilschut, T. Daemen, Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs, Biosci. Rep. 22 (2002) 323-338. (Pubitemid 35222739)
111. L. Bungener, A. Huckriede, A. De Mare, J. De Vries-Idema, J. Wilschut, T. Daemen, Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity, Vaccine 23 (2005) 1232-1241. (Pubitemid 40126526)
112. L. Bousarghin, P. Hubert, E. Franzen, N. Jacobs, J. Boniver, P. Delvenne, Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells, J. Gen. Virol. 86 (2005) 1297-1305. (Pubitemid 40613246)
113. D.M. Da Silva, S.C. Fausch, J.S. Verbeek,W.M. Kast, Uptake of human papillomavirus virus-like particles by dendritic cells ismediated by Fc{gamma} receptors and contributes to acquisition of T cell immunity, J. Immunol. 178 (2007) 7587-7597. (Pubitemid 46898028)
114. J. Angel, L. Chaperot, J.P. Molens, P. Mezin, M. Amacker, R. Zurbriggen, A. Grichine, J. Plumas, Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells, Vaccine 25 (2007) 3913-3921. (Pubitemid 46613829)
115. P. Lacasse, J. Denis, R. Lapointe, D. Leclerc, A. Lamarre, Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation, J. Virol. 82 (2008) 785-794.
116. G. Sailaja, I. Skountzou, F.S. Quan, R.W. Compans, S.M. Kang, Human immunodeficiency virus-like particles activate multiple types of immune cells, Virology 362 (2007) 331-341. (Pubitemid 46678140)
117. L. Flatz, A.N. Hegazy, A. Bergthaler, A. Verschoor, C. Claus, M. Fernandez, L. Gattinoni, S. Johnson, F. Kreppel, S. Kochanek, M.v.d. Broek, A. Radbruch, F. Levy, P.-H. Lambert, C.-A. Siegrist, N.P. Restifo, M. Lohning, A.F. Ochsenbein, G.J. Nabel, D.D. Pinschewer, Development of replication-defective lymphocytic horiomeningitis virus vectors for the induction of potent CD8+ T cell immunity, Nat. Med. 16 (2010) 339-345.
118. A. Villegas-Mendez,M.I. Garin, E. Pineda-Molina, E. Veratti, J.A. Bueren, P. Fender, J.-L. Lenormand, In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity, Mol, Ther (2010).
119. A.M. Daines, B.W. Greatrex, C.M. Hayman, S.M. Hook, W.T. McBurney, T. Rades, P.M. Rendle, I.M. Sims, Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systems, Bioorg. Med. Chem. 17 (2009) 5207-5218.
120. F. Zhou, L. Huang, Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway, Immunomethods 4 (1994) 229-235. (Pubitemid 24318706)
121. L. Bungener, K. Serre, L. Bijl, L. Leserman, J. Wilschut, T. Daemen, P. Machy, Virosome-mediated delivery of protein antigens to dendritic cells, Vaccine 20 (2002) 2287-2295. (Pubitemid 34497039)
122. E.V.L. Grgacic, D.A. Anderson, Virus-like particles: passport to immune recognition, Methods 40 (2006) 60-65. (Pubitemid 44415499)
123. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, K. Palucka, Immunobiology of Dendritic Cells, Ann. Rev. Immunol. 18 (1) (2000) 767-811. (Pubitemid 30365397)
124. J.A. Villadangos, P. Schnorrer, Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo, Nat. Rev. Immunol. 7 (7) (2007) 543-555. (Pubitemid 46987783)